.jpg "Women-Founded Companies In Pharmaceutical Industry")
.jpeg "Merck Phase 3 HIV Findings Reinforce Safety in Weight and Lipids")
India's Path to Billion-Dollar Drugs: Building a Strong Ecosystem
Rehan Khan, Managing Director, MSD India
Rehan Khan, Managing Director of MSD India, shares that India has more unicorn startups than billion-dollar drugs. Despite a huge patient pool with diabetes, hypertension, and cancer, the country...
Making Healthcare Affordable: GST Reforms...
Zeenat Parween, Correspondent, India Pharma Outlook
The recent GST Reform by the Government of India to exempt individual health and life insurance premiums, along with the rationalization of...
Advancements in Computer-Aided Drug Design for...
Computer aided drug design (CADD) has played a pivotal role in...
.png "Max Healthcare Plans Rs 5,000 Cr Capex to Add 4,200 Beds by FY28")
India's Path to Billion-Dollar Drugs: Building a Strong Ecosystem
Rehan Khan, Managing Director of MSD India, shares that India has more unicorn startups than billion-dollar drugs. Despite a huge patient pool with diabetes, hypertension, and cancer, the country...
New Dynamics of Drug Distribution, Free Medicine Schemes in India
K C Bansal, Chairman & Managing Director, DK Enterprises
The distribution was completely disregarded in this country. However, the time has come since distribution does not just imply taking the product...
Bridging Collaboration Gaps to Boost India's Pharma Discovery
Dr. Sadhna Joglekar, Senior VP & Head of Global Drug Development India, Novartis
India’s biotech and pharmaceutical R&D journey began much earlier than many believe, with its foundations laid in the 1990s and early 2000s. Indian...
India's Innovative Therapies Set Global Standard at Low Cost
Amit Mookim, CEO, Immuneel Therapeutics
Today, ensuring innovation remains accessible is paramount. We are now able to deliver therapies like CAR-T at 5–8% of the cost compared to the...
Most Viewed
Making Healthcare Affordable: GST Reforms...
Zeenat Parween, Correspondent, India Pharma Outlook
The recent GST Reform by the Government of India to exempt individual health and life insurance premiums, along with the rationalization of...
Oral GLP-1 Drugs: Expanding Patient Access in Obesity and Diabetes Care
Zeenat Parween, Correspondent, India Pharma Outlook
The last ten years have seen unprecedented international momentum in GLP-1 obesity and...
.jpg "Top 10 Indian Ayurvedic Brands in Modernizing Ancient Care")
Top 10 Indian Ayurvedic Brands in Modernizing Ancient Care
The Top 10 Indian Ayurvedic Medicine Companies that are transforming the ancient system of...
Pharma Compliance Software 2025 :Smarter Solutions for Regulatory Success
Aravindan R, Correspondent, India Pharma Outlook
Pharma compliance software is significant for Pharmaceutical regulations, and it set to...
Advancements in Computer-Aided Drug Design for...
Computer aided drug design (CADD) has played a pivotal role in...
The Future of Kidney Transplants in India
A milestone has been achieved by Fortis Hospital, Bengaluru...
Why India is Gaining Popularity for Clinical Trials
India has successfully performed the first human clinical...
.jpg "Usage of Conversational AI in the Health Insurance Sector")
Usage of Conversational AI in the Health Insurance Sector
At the Conversational AI and Customer Experience summit last...